Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.
This article is from
The Cancer Letter
archive.
Vol. 29 No. 42 | November 14, 2003
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit
March 30, 2012
TCL Archive
Wynder, Doll, Hill Share Ochsner Award
September 23, 1988
TCL Archive
Central Line Safety Intervention Lowers Patient Infection Rate
October 25, 2013
TCL Archive
Budge Act Includes Language On Coverage Of Oral Cancer Drugs
August 13, 1993
TCL Archive
Authorization Bill Passes Senate 82-0
June 27, 1980
TCL Archive
ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials
May 18, 1984